Clinical trials: E-cigarette
Cigarette Smoking
Contingency Management for Smoking in Substance Abusers
Patients (N=102) who meet diagnostic criteria for alcohol, cocaine, marijuana, or opiate abuse or dependence will meet with research staff on two days for quit preparation sessions (2 per day).
- Trial name
- R21 (NCT00683033)
- Testing
- Contingency Management, Brief smoking cessation counseling
- Where
- United States
- Volunteers
- 51 people
- Sponsor
- UConn Health
Cigarette Smoking
The Effectiveness of Smoking Cessation Guidelines in the Emergency Department
Although 78% of smokers report that a health professional has previously advised them to quit smoking, most smokers are not advised to stop smoking or offered assistance with smoking cessation during a given ED visit.
- Trial name
- NCT00756704
- Testing
- Smoking cessation guideline implementation
- Where
- 2 sites in United States
- Volunteers
- 789 people, healthy volunteers welcome
- Sponsor
- University of Iowa
Cigarette Smoking, Nicotine Dependence
School Nurse-Delivered Smoking Cessation Intervention
The purpose of this study is to conduct a randomized controlled school-based trial to evaluate the effectiveness of a four-session school nurse-delivered smoking cessation intervention in increasing abstinence rates among high…
- Trial name
- NCT00682474
- Testing
- Counseling Intervention, Information Intervention
- Where
- United States
- Volunteers
- 1,058 people, healthy volunteers welcome
- Sponsor
- University of Massachusetts, Worcester
Cigarette Smoking, Tobacco Use
Gabapentin for Smoking Cessation
Gabapentin is an anti-epileptic agent that has shown preliminary evidence of efficacy for improving symptoms of cocaine and alcohol withdrawal in pilot studies.
- Trial name
- NCT00578552
- Testing
- Gabapentin - 1800 mg/day, Gabapentin - 2700 mg/day
- Where
- United States
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
Cigarette Smoking, Tobacco Smoking
Working Inside for Smoking Elimination
The purpose of this study is to determine the extent to which an Intentional Behavioral Intervention will increase tobacco quit rates post release among incarcerated men and women.
- Trial name
- WISE (NCT01122589)
- Testing
- Motivational Interviewing/CBT, CONcise Tapes Reviewing Obstacles to healthy Living (CONTROL)
- Where
- United States
- Volunteers
- 350 people, healthy volunteers welcome
- Sponsor
- Memorial Hospital of Rhode Island
Tobacco Use Disorder
Acute Effects of Smoking on Airway Dendritic Cells
Airway dendritic cells control pulmonary immune responses to inhaled particles. It is the aim of the present study to investigate the acute effects of smoking on the number and surface molecule expression of human airway…
- Trial name
- NCT00740896
- Testing
- Smoking
- Where
- Germany
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- University of Rostock
Smoking
Treatment to Quit Smoking
This protocol evaluates the efficacy of combining pharmacologic treatments for smoking cessation, entailing the use of the nicotine skin patch with the nicotinic antagonist mecamylamine, with a specific behavioral therapy…
- Trial name
- NCT00018161
- Testing
- Mecamylamine, Nicotine Patch, Cigarette brand switching
- Where
- United States
- Sponsor
- US Department of Veterans Affairs
Schizophrenia
Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
This study will use single photon emission computed tomography (SPECT) to study brain nicotine receptors (proteins on the surface of brain cells) in healthy subjects and in patients with schizophrenia.
- Trial name
- NCT00061789
- Testing
- SPECT Imaging of Nicotinic Acetylcholine Receptors in Brain
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- National Institute of Mental Health (NIMH)
Schizophrenia, Cognition
Effects of Atomoxetine on Cognitive Function in Schizophrenia
The purpose of this study is to examine the effects of atomoxetine (Strattera™) on prefrontal cognitive functioning in persons with schizophrenia.
- Conditions
- Schizophrenia, Cognition, Smoking
- Trial name
- NCT00420498
- Testing
- Atomoxetine (Strattera™)
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Yale University
Depressive Disorder
Nicotinic Receptor Augmentation of SSRI Antidepressants
The purpose of this study is to determine whether the nicotinic receptor antagonist mecamylamine hydrochloride (Inversine) can augment SSRI-refractory major depression symptoms, quality of life and cigarette smoking outcomes.
- Trial name
- NCT00319319
- Testing
- Mecamylamine hydrochloride (Inversine)
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Yale University
Cardiovascular Diseases
Chronic and Acute Effects of Smoking on the Left and Right Ventricular Relaxation in Young Healthy Smokers
Impairment of relaxation, the early phase of ventricular diastole is the first stage of heart diastolic dysfunction. Left ventricular diastolic function can be determined noninvasively by Echo- Doppler - derived mitral valve flow…
- Trial name
- NCT00395928
- Where
- Poland
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- Medical University of Warsaw
Smoking Status, Cigarette Consumption
Analysis of 'Tobacco and Alcohol Tax Law' and Its Impact on Cigarette Consumption
This project is the survey on smoking behavior in Taiwan. The survey information will be used to analyze the influence of the earmarked tax of cigarettes on (1)the consumption of cigarette,(2)the substitution between the…
- Trial name
- NCT00262158
- Volunteers
- 4,000 people
- Sponsor
- National Health Research Institutes, Taiwan